GD2 targeting CAR T cells for neuroblastoma

Treatment of neuroblastoma is a significant clinical unmet need in paediatric oncology epitomised by high-risk disease in which relapse is common and outcomes for children with relapse or primary refractory disease are typically poor, with 4-year progression-free survival for relapse/refractory dise...

Full description

Saved in:
Bibliographic Details
Main Authors: John Anderson, Giuseppe Barone, Alexandra Zehner
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:EJC Paediatric Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772610X24000382
Tags: Add Tag
No Tags, Be the first to tag this record!